講演録DL - 一般財団法人 医療関連サービス振興会
Contents
1.2. 26 1
3. 1
4. 9
5. virulence 4 Vo 736 August 2075 3 5
6. MR 1 1
7. 31 160 2002 400 5 2014
8. 8 ew Vo 736 August 2075
9. 76 Vol 136 August 2075 _ 1 APIC UV W BIS a 9 UV 5 1 uvpa360 M
10. 22 Vol 136 August 2075 PPE lt PPE PPE ou
11. 13 13 n Di MN
12. Vo 736 August 2075 3 Clostridium difficile 7 Clostridium difficile 3 2 2 0 0 196 2 PA toxinA toxinB binary py Re NN
13. 8 81 Vo 736 August 2075 A gt Q 1 A 1 4 PPE
14. B 58 Vo 736 Augus 2075 17 59
15. 1 a
16. 42 2 43 Vol 136 August 2075
17. 10 CC personal protective equipment PPE e e e e e e 2 9 e e
18. 3 48 48
19. 51 53 _ pe 2 ro Cafficike Na CDI oxin Ns
20. JE 1 23 23
21. IM IL 15 1 80
22. 8 Vol 136 August 2075 6 7 3
23. x 69 3 CF 1 T i Vo 736 Augusr 2075
24. 68 2 68 Vol 136 August 2075 9 3 1 69
25. 2 lt 9 6 US U U A 55
26. 78 Vo 736 Augusr 2075 2 MBL F c ogcge 4 24 78 4 UV 1 2 3 4 4
27. 38 236 BUUE9 Sim 2 fa 2 ee mm AM lt As 8 PPE 39 PPE 4 0 Vo 736 Augusr 2075
28. 4 ATP 2
29. 5 um sec ropler Droplef nuclel lt 5 m 0 06 1 5cm sec 29 29 5um 4
30. 0 OO 70 M Vol 136 August 2075 2SD 4 3
31. Vo 736 Augusr 2075
32. a EE 17 17 A A
33. 6 62 2 gt r 0 97403 1 DF w A 5 4 37 20 833 Bt 0 10 10 o 10 6 7 96 0 004 et 10 8 2 6 2 110 8 18 60 15 4 slio 1Ol4 e e 69 sls 6 6 e io io s 8 oo2 5 25 4 20 3 15 2 10 1 5 x1 25 3 5 15 4 12 3 10 2 5 1 3 x5
34. 63 2 an ATP CZ lt 2 ATP EE gt
35. B gt Q 2 ICN A2 s s
36. PPE Personal Protective Equipment PPE CV wi PPE PPE 1 _ lt 0 na 3 4 amp 2 20
37. 24 Vol 136 August 2075 PPE PPE PPE em 2 0 amp A 5 rme ER 6 9 hk 6 0 2 a N x a 1 me
38. au 4 33 a 33 Vo 736 Augus 2075 34 GPC GNR 34 35
39. 6 Vol 136 August 2075 3 2 1 standard precautions 2 3 7 4 1
40. MDRA MDRP MDRP 2 rv iv 37 Vo 736 Augus 2075 38
41. A CRE AmpC 3 IS MDRA N 3 2 2 FN MDRP 2 2 AmpC lt
42. im SN 16 Vol 136 August 2075 em ee oe 2
43. 5 4 3 i ES 2 NG 4 gt ce A OE a 6 3
44. voIl 2 2014 1 3 5015 5 56014 4 Vo 736 August 2075
45. F i 2 6b 11 5 5 5 a _ ra 7
46. 10 14 HAI 3
47. PPE N95 e 1 PPE N95 30 Vo 736 Augus 2075 N95 N95
48. ee CRE 76 2
49. 80 Vol 136 August 2075
50. bp 72 3 Vo 736 August 2075 CRE 73 A
51. 2 BCEL CGN 786 Vo 736 August 2075 1 20 75 Ce 3 sw
52. 1 14 14 Vol 136 August 2075 14 NR 0 FFLFOre i A ik
53. PPE 49 50 CDI P ae MU 4 T m PPE CDI nm Vol 136 August 2075 51 CDI
54. 5 2 15 14 4 7 23 205 15 2
55. 1 1 28 1 000 SL 2
56. UV 24 UV UV 24 4
57. 15 rt ts PT Mi 1
58. ea ii 0 Pr PPE PPE 41 41 Vo 736 Augus 2075 6 1 SPP Sb CS
59. 3 1 Vol 136 August 2075 3 3 2 s MRSA MDRP VRE MDRA ESBL MBL
60. 23 Vo 736 August 2075 PPE _PPE gt amp a a an Runa idc Ran a EE
61. 35 Vol 136 August 2075 a DNAF a lt DT e090e ee NN i A B 9 VA p 36 GNR 36 ESBL AmpC M
62. 1 Vol 136 August 2075 1
63. 21 PPE 2 PPE gt W eco 2 4 j TI a 22
64. 1 1 1 8 3 4 5 6 5 2 15 14 4 7 8 1 1
65. PPE 2 a 1 ee a 40 PPE P PE _
66. 79 3 Level4 Ph g levels Th
67. 396 2 89 PP gt 10 20 Rs 72 2 gt gt ee J CDI 44 ENM MI 26 ON
68. 9 Y 24 3
69. 2 3 4 5 6 7 6 8 2 2 2 Vo 736 Augus 2075 2 1 Et oo e
70. 3 lt 2S RE SANE A FAN WECM NS PPE 32
71. gt pm SS 2 0 i 1 2 9 30 100 ie SN III NT 5 5
72. 25 25 PPE 5 1 2m 26 Y Y Vo 736 Augus 2075 3 27 1
73. 6 000 0 4 000 9 000 3 000 2 000 1 000 0 B C D E _ Y Es a Co Pa 3 C gt gt gt 4 58 9 000
74. 20 Vo 736 Augus 2075 PPE PPE eeeeneaseeaeeonacnaaeaorraaaaaey lt Nl QO rm es 1 ee 9 2 0 ot Sms WALAG a Boo rrr re yp TT
75. sw 64 je Vo 736 Augusr 2075 2 am mp Na a e 4 fig gd
76. Staphylococcus epidermialis Staphylococcus aureus Streptococcus pyosgenes A Streptococcus agalactiae B GP C B Enterococcus scherichia CO Klebsiella pneumoniae Serratia marcescens Pseudomonas aeruginosa Acinetobacter baumannii GNR Citrobacter freundli Enterobacter cloacae 34 A BB BB C
77. 2 wR gt 3 5 a EA 6 a 10 2 2 5W 70
78. 8 10 1 55 Vo 736 Augus 2075 2 MR OE ON _ a A i 0 56 i ml ah 56 2 6
79. x B 1 x
80. 4 3 71 B IMP AZT MBL NDM 1 New Delhi metallo B lactamase 1 KPC Klebsiella pneumoniae Carbapenemase
81. 27 7 5um droplet el lt m s 1 m PPE PPE 28
82. 3 mW CRE 1 2 3 NL 3 5 UV CRE 79 UVC
83. 48 CDI CDI Eee FT ET EE of 1 3 CDI CDI ee ep Ar 2 4 oi EA ICN 8 Vol 136 August 2075
84. 7 9 1 12 Vo 736 Augus 2075 13 mm PF 2 4 gt be ORS 0S OME OI 13
85. 8 1 15 en kw 60 136 64 B 91 B 60 T7 1 Ox 0 F cas Bi 59 17 x 59 2 136 120 8 21
86. Carbapenem resistant enterobacteriaceae CRE UE 3 2014 9 19 5 i 71 CRE 9 5 NDM 1 1 KPC
87. A3
88. 201 1 MBL c pgcge 62015 04 6015 0 C ostridium qdifficile 014 06 2014 06 ATP 2013 04 6013 0
89. 31 M S
90. B 3 CRE 3 A hower toilet cc 0 i
91. gt 65 65 2 66 xs CN 10 Vo 736 August 2075
92. Vo 736 August 2075 RS 0 1 1 1 Vo 736 August 2075
93. RS Se gt I nosocomial infection PR 48 gt gt Healthcare Associated Infection 3
94. TP
95. EPA EPA 1 1 1 1 2 100H 1 3 EPA UU RR WwW NM EPA EPA 57 57 Vol 136 August 2075 2
96. 1 3 2 12 1 2 3 1 2 6 4 1 1
97. ee dit ad masinina eo 2013 9 74
98. e MRSA 10 WM Vol 136 August 2075 2 2 2 9 7 wm a 4 NRN a EE M 7
99. rw 4 8 2 11 9 3 S
100. 0 1 44 7 1 1 CDI CDI CDI 45 45 Vol 136 August 2075 46 47
101. Vo 736 August 2075 4 1 2 1 1 nt ME le 1 RE 8 4 75 10 4
102. 75 3 61 2 2013 9 1 unkRuw hm 62 Vol 136 August 2075 s 2 ESBL UER TEGANADNE WDEGS 6 CC OFLELT MECCOE
103. 1 2 54 1 CDI lt 1 2 3 VCM MNZ10 14 BM3g 4 CDI 5 54 8 2 1
104. Vol 136 August 2075 2 gt 1 gt gt a N a 4
105. Vol 136 August 2075 N 29 5m 2
106. 1 1 N f NN TT 9 1 2013 6 5 1 20
107. 10 10 ICN ICN 2006 1 MDRP PPE
108. 2 31 N95 gt Ah NT EH BA gt A 2y J 1 WW fn N95 1 DN95
109. ESBL 63 0 1 a ATP 4 7 7702 ATP 500 U RE
110. 2 J Se l 1 JI UI 2mwymmcgot maexaeczcemo 23 PPE
111. 26 0 80 64 2 54 40 44 ma _ 20 mn aa 0 em B C D E 60 Vo 736 August 2075 RT 01 61
112. N95 a a he RE gh pk N95 N95 1 e 2 am 9 i ce N95 J Ss lt N95
113. B 1 8 B 67 2 1 2013 6 19 81 99 2 2013 10 2 B 82 9 1 8 06 04 02 oO A G8 Ds 1 08 06 0402 0 02 04 oe 08 1 1 0 xX 1 am 8 BB 4333933881 em i MRBA mm MDRP ESBL MBL 1 Vo 736 August 2075
114. 1 7 6 16 15 00 17 00 Bl 2008 2012 2012 2014 G014 005 008 S013 011 014 G005
115. DS 6 18 Vol 136 August 2075 4 Personal Protective Equipment PPE PPE Personal Protective Equipment 19 PPE PPE PPE OS
116. Lewel 3 5 4 rrr a 1 ar er Cree aes 80 CMMI amp
117. UVDI 360 PJ UVC ET 77 m 9996 0 9m 2 4m 3 6m 2A 1 1 2 2 2 3 2 3 4 1 lt A baumannii MRSA 1 2 2 1 2 3 K pneumoniae 1 2 3 ye VRE Il 1 gt 3 C difficile 3 4 TE 2 4 5 i
118. 0 Vo 736 August 2075 C gt Q 3
119. DRP GNR 2 Acine obacfer MDRA 2 Acine obacfer 0g2 NDM 2 MRSA VRE ESBL CRE 35 ESBL 3 4
Download Pdf Manuals
Related Search